The Value of Patient Support Programs During COVID-19
Nicole Hebbert (SVP, Head of Patient Support Services, UBC), Jennifer Lim (Director of Patient Services, UBC), UBC partner SK Life Science and various industry experts spoke with PharmExcec.com about the impact a patient support program or ‘Hub’ can have on patients and prescribers during a pandemic.
Assets in Anxious Times: Patient Hubs Demonstrate Value During COVID-19 article explores in detail how a hub can ease patient access, drive patient engagement, and more effectively enable speed and efficiency to therapy through technology – even throughout a global pandemic.
In-person visits have drastically prohibited patients from visiting the site of care, whether from shelter-at-home mandates, office closures, or potential fear from patients exposing themselves to the virus, hub services can ease patient’s treatment anxiety and provide supplemental options to navigate their access.
During the COVID-19 pandemic, UBC has quickly and efficiently transitioned to a dynamic remote model without client interruptions. The team has supported three different launches since March across a broad range of indications from diabetes to epilepsy. Our in-home and telephonic nurse network has provided both clients and patients the peace of mind that care will not be interrupted, and the needs of patients will continue to be prioritized.
UBC’s patient support services can be customized to meet unique program and product objectives while addressing the needs and requirements of patients, caregivers, prescribers, pharmacists, payers, and regulators. UBC applies a holistic approach to the patient care continuum designed to maximize a product’s market penetration as well as its growth potential.
To get in touch with UBC to learn how we can provide patient support programs during COVID-19 and beyond, head here.